Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Glioblastoma (GBM) is a rare brain tumor that can rapidly grow and spread into nearby brain tissue. It is difficult to treat and has a poor prognosis.

Treatment is a challenging task, due to the location and complexity of the tumor. Glioblastoma is not surgically curable because the tumor has left behind cells deep into the brain that can grow again. That’s why many treatments fail or are ineffective for glioblastoma patients. Also, the brain has a special protective barrier called the blood-brain barrier that protects the brain from poison, and most chemotherapies are considered poisonous.

However, progress has been made for treating GBM including the use of Tumor Treating Fields, as well as investigational therapies such as medications that can potentially cross the blood-brain barrier and next-generation sequencing.

We’ll hear more from Dr. Sigmund Hsu and a patient who was diagnosed with a GBM 15 years ago.

 

BioTE Medical is a leader in precision and preventive medicine. They create patient-centric strategies that optimize hormones for women and men.

The Oxford Gold Group was founded on the belief that everyone should have the opportunity to afford and benefit from owning precious metals. They tailor investment strategies for each investor based on their specific needs.

TruSculpt iD and truSculpt flex offer you a total body solution to remove fat, renew skin, and rebuild muscle.

Comments

comments